mLabs  SARS-CoV-2 IgG/IgM Assay


COVID-19 Antibody Test

Rapid Results in 4-8 Minutes


The mLabs SARS-CoV-2 IgG and IgM assay is a fluorescent microparticle immunoassay intended for the qualitative detection of the total IgC and IgM antibodies to SARS-CoV-2 in human whole blood, and plasma.

All samples were collected from individuals who were confirmed as positive or negative for the SARS-CoV-2 virus by various (FDA-authorized) PCR tests.


  • Easy-to-use touchscreen operation

  • Fast: qualitative results in 4-8 minutes

  • Stable: the signal is stable after testing and remains constant for at least 30 minutes

  • Patented microfluidic technology enables highly precise and reliable qualitative fluorescence immunoassay testing


COVID-19 Antibody Test Resources:


Instructions for Use (OUTSIDE OF USA)

mLabs SARS-CoV-2 IgG/IgM assay is FDA-submitted and EUA-submitted, and in review.




To contact Micropoint to find out more or to purchase mLabs SARS-CoV-2 IgG/IgM assay, please email:




U.S. Headquarters


Micropoint Bioscience, Inc.
3521 Leonard Court 
Santa Clara, CA 95054
United States


T:+1 (408) 588-1682
F:+1 (408) 588-1620



European Office


Micropoint Bioscience, Inc.

2 rue Eugene Sue

38100 Grenoble



T: +33 6 22 38 20 48

F: +33 4 76 09 03 50

Asian Office


Micropoint Biotechnologies Co., Ltd.

5F, Bldg 1

Runheng Dingfeng Industrial Park, Liuxian 2 Rd.

Shenzhen 518101, Guangdong



T: +86 755 21600849

F: +86 755 86673903

Copyright Micropoint Biosciences 2016

Micropoint Bioscience products are not available for sale nor marketed in the United States at this time.